Cannabis Sativa Stock Performance
| CBDS Stock | USD 0.05 0.02 63.21% |
Cannabis Sativa holds a performance score of 19 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.57, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cannabis Sativa will likely underperform. Use Cannabis Sativa treynor ratio and the relationship between the semi variance and period momentum indicator , to analyze future returns on Cannabis Sativa.
Risk-Adjusted Performance
19 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Sativa are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting fundamental indicators, Cannabis Sativa unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 322.1 K | |
| Total Cashflows From Investing Activities | 22.7 K |
Cannabis |
Cannabis Sativa Relative Risk vs. Return Landscape
If you would invest 0.63 in Cannabis Sativa on August 29, 2024 and sell it today you would earn a total of 3.94 from holding Cannabis Sativa or generate 625.4% return on investment over 90 days. Cannabis Sativa is currently generating 5.0915% in daily expected returns and assumes 20.7461% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Cannabis, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cannabis Sativa Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannabis Sativa's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Cannabis Sativa, and traders can use it to determine the average amount a Cannabis Sativa's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2454
| Best Portfolio | Best Equity | CBDS | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 20.75 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.25 actual daily | 19 81% of assets perform better |
Based on monthly moving average Cannabis Sativa is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannabis Sativa by adding it to a well-diversified portfolio.
Cannabis Sativa Fundamentals Growth
Cannabis OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cannabis Sativa, and Cannabis Sativa fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cannabis OTC Stock performance.
| Return On Equity | -0.54 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.56) % | |||
| Operating Margin | (0.79) % | |||
| Current Valuation | 1.2 M | |||
| Shares Outstanding | 44.87 M | |||
| Price To Earning | (7.53) X | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 1.15 X | |||
| Revenue | 1.84 M | |||
| EBITDA | (2.09 M) | |||
| Cash And Equivalents | 507.7 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 125.46 K | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (245.99 K) | |||
| Earnings Per Share | (0.07) X | |||
| Total Asset | 2.56 M | |||
| Retained Earnings | (76.83 M) | |||
| Current Asset | 79.73 K | |||
| Current Liabilities | 371.82 K | |||
About Cannabis Sativa Performance
Assessing Cannabis Sativa's fundamental ratios provides investors with valuable insights into Cannabis Sativa's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cannabis Sativa is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. Cannabis Sativa operates under Health Information Services classification in the United States and is traded on OTC Exchange.Things to note about Cannabis Sativa performance evaluation
Checking the ongoing alerts about Cannabis Sativa for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cannabis Sativa help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cannabis Sativa is way too risky over 90 days horizon | |
| Cannabis Sativa has some characteristics of a very speculative penny stock | |
| Cannabis Sativa appears to be risky and price may revert if volatility continues | |
| Cannabis Sativa has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.84 M. Net Loss for the year was (2.45 M) with profit before overhead, payroll, taxes, and interest of 1.14 M. | |
| Cannabis Sativa currently holds about 507.7 K in cash with (245.99 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 39.0% of the company shares are held by company insiders |
- Analyzing Cannabis Sativa's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cannabis Sativa's stock is overvalued or undervalued compared to its peers.
- Examining Cannabis Sativa's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cannabis Sativa's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cannabis Sativa's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Cannabis Sativa's otc stock. These opinions can provide insight into Cannabis Sativa's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cannabis OTC Stock Analysis
When running Cannabis Sativa's price analysis, check to measure Cannabis Sativa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Sativa is operating at the current time. Most of Cannabis Sativa's value examination focuses on studying past and present price action to predict the probability of Cannabis Sativa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Sativa's price. Additionally, you may evaluate how the addition of Cannabis Sativa to your portfolios can decrease your overall portfolio volatility.